{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:12:01Z","timestamp":1793725921186,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00198-025-07677-w","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:09:36Z","timestamp":1757344176000},"page":"2555-2566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1536-706X","authenticated-orcid":false,"given":"Ye","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisakha","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"7677_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/jbmr.2888","volume":"31","author":"S Khosla","year":"2016","unstructured":"Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res 31:1485\u20131487. https:\/\/doi.org\/10.1002\/jbmr.2888","journal-title":"J Bone Miner Res"},{"key":"7677_CR2","unstructured":"EVENITY Label Information DF EVENITY Label Information. April 9, 2019 edn"},{"key":"7677_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00198-016-3886-y","volume":"28","author":"A Modi","year":"2017","unstructured":"Modi A, Sajjan S, Insinga R, Weaver J, Lewiecki EM, Harris ST (2017) Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years. Osteoporos Int 28:1355\u20131363. https:\/\/doi.org\/10.1007\/s00198-016-3886-y","journal-title":"Osteoporos Int"},{"key":"7677_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa756","author":"E Tsourdi","year":"2020","unstructured":"Tsourdi E, Zillikens MC, Meier C et al (2020) Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa756","journal-title":"J Clin Endocrinol Metab"},{"key":"7677_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427. https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"key":"7677_CR6","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","volume":"21","author":"I Imaz","year":"2010","unstructured":"Imaz I, Zegarra P, Gonz\u00e1lez-Enr\u00edquez J, Rubio B, Alcazar R, Amate JM (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943\u20131951. https:\/\/doi.org\/10.1007\/s00198-009-1134-4","journal-title":"Osteoporos Int"},{"key":"7677_CR7","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1185\/030079907x242890","volume":"23","author":"CA McHorney","year":"2007","unstructured":"McHorney CA, Schousboe JT, Cline RR, Weiss TW (2007) The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin 23:3137\u20133152. https:\/\/doi.org\/10.1185\/030079907x242890","journal-title":"Curr Med Res Opin"},{"key":"7677_CR8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00198-020-05507-9","volume":"31","author":"G Koller","year":"2020","unstructured":"Koller G, Goetz V, Vandermeer B, Homik J, McAlister FA, Kendler D, Ye C (2020) Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteoporos Int 31:2093\u20132102. https:\/\/doi.org\/10.1007\/s00198-020-05507-9","journal-title":"Osteoporos Int"},{"key":"7677_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/gme.0b013e3181fda7e7","volume":"18","author":"DC Gomes","year":"2011","unstructured":"Gomes DC, Costa-Paiva L, Farhat FC, Pedro AO, Pinto-Neto AM (2011) Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass. Menopause (New York, NY) 18:531\u2013536. https:\/\/doi.org\/10.1097\/gme.0b013e3181fda7e7","journal-title":"Menopause (New York, NY)"},{"key":"7677_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00198-012-2221-5","volume":"24","author":"C Hansen","year":"2013","unstructured":"Hansen C, Pedersen BD, Konradsen H, Abrahamsen B (2013) Anti-osteoporotic therapy in Denmark\u2013predictors and demographics of poor refill compliance and poor persistence. Osteoporos Int 24:2079\u20132097. https:\/\/doi.org\/10.1007\/s00198-012-2221-5","journal-title":"Osteoporos Int"},{"key":"7677_CR11","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1001\/jama.2019.18055","volume":"322","author":"M Silverstein","year":"2019","unstructured":"Silverstein M, Hsu HE, Bell A (2019) Addressing social determinants to improve population health: the balance between clinical care and public health. JAMA 322:2379\u20132380. https:\/\/doi.org\/10.1001\/jama.2019.18055","journal-title":"JAMA"},{"key":"7677_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/pds.2344","volume":"21","author":"HM Devold","year":"2012","unstructured":"Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ (2012) Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway. Pharmacoepidemiol Drug Saf 21:297\u2013304. https:\/\/doi.org\/10.1002\/pds.2344","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7677_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/s0140-6736(20)30893-x","volume":"395","author":"AV Dorn","year":"2020","unstructured":"Dorn AV, Cooney RE, Sabin ML (2020) COVID-19 exacerbating inequalities in the US. Lancet (London, England) 395:1243\u20131244. https:\/\/doi.org\/10.1016\/s0140-6736(20)30893-x","journal-title":"Lancet (London, England)"},{"key":"7677_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.semvascsurg.2021.08.002","volume":"34","author":"EA Andraska","year":"2021","unstructured":"Andraska EA, Alabi O, Dorsey C, Erben Y, Velazquez G, Franco-Mesa C, Sachdev U (2021) Health care disparities during the COVID-19 pandemic. Semin Vasc Surg 34:82\u201388. https:\/\/doi.org\/10.1053\/j.semvascsurg.2021.08.002","journal-title":"Semin Vasc Surg"},{"key":"7677_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/eurpub\/ckab047","volume":"31","author":"CM Roy","year":"2021","unstructured":"Roy CM, Bollman EB, Carson LM, Northrop AJ, Jackson EF, Moresky RT (2021) Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: a scoping review. Eur J Public Health 31:634\u2013640. https:\/\/doi.org\/10.1093\/eurpub\/ckab047","journal-title":"Eur J Public Health"},{"key":"7677_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jclinepi.2016.02.011","volume":"76","author":"H Kumamaru","year":"2016","unstructured":"Kumamaru H, Gagne JJ, Glynn RJ, Setoguchi S, Schneeweiss S (2016) Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications. J Clin Epidemiol 76:200\u2013208. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.02.011","journal-title":"J Clin Epidemiol"},{"key":"7677_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.15585\/mmwr.mm6942a3","volume":"69","author":"S Dasgupta","year":"2020","unstructured":"Dasgupta S, Bowen VB, Leidner A et al (2020) Association between social vulnerability and a county\u2019s risk for becoming a COVID-19 hotspot - United States, June 1-July 25, 2020. MMWR Morb Mortal Wkly Rep 69:1535\u20131541. https:\/\/doi.org\/10.15585\/mmwr.mm6942a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7677_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.15585\/mmwr.mm7012e1","volume":"70","author":"MM Hughes","year":"2021","unstructured":"Hughes MM, Wang A, Grossman MK et al (2021) County-level COVID-19 vaccination coverage and social vulnerability - United States, December 14, 2020-March 1, 2021. MMWR Morb Mortal Wkly Rep 70:431\u2013436. https:\/\/doi.org\/10.15585\/mmwr.mm7012e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7677_CR19","doi-asserted-by":"publisher","first-page":"116954","DOI":"10.1016\/j.bone.2023.116954","volume":"178","author":"Y Liu","year":"2024","unstructured":"Liu Y, Arora T, Zhang J, Sodhi SK, Xie F, Curtis JR (2024) The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare. Bone 178:116954. https:\/\/doi.org\/10.1016\/j.bone.2023.116954","journal-title":"Bone"},{"key":"7677_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/acr.21638","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, Yun H, Matthews R, Saag KG, Delzell E (2012) Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population. Arthritis Care Res (Hoboken) 64:1054\u20131060. https:\/\/doi.org\/10.1002\/acr.21638","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7677_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2474-15-112","volume":"15","author":"H Yun","year":"2014","unstructured":"Yun H, Curtis JR, Guo L et al (2014) Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries. BMC Musculoskelet Disord 15:112. https:\/\/doi.org\/10.1186\/1471-2474-15-112","journal-title":"BMC Musculoskelet Disord"},{"key":"7677_CR22","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","volume":"29","author":"CT Yeam","year":"2018","unstructured":"Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623\u20132637. https:\/\/doi.org\/10.1007\/s00198-018-4759-3","journal-title":"Osteoporos Int"},{"key":"7677_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/pds.3377","volume":"22","author":"M Tadrous","year":"2013","unstructured":"Tadrous M, Gagne JJ, St\u00fcrmer T, Cadarette SM (2013) Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf 22:122\u2013129. https:\/\/doi.org\/10.1002\/pds.3377","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7677_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/acr.21805","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, Xie F, Chen L et al (2012) Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 64:1480\u20131489. https:\/\/doi.org\/10.1002\/acr.21805","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7677_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pds.1845","volume":"19","author":"SM Cadarette","year":"2010","unstructured":"Cadarette SM, Gagne JJ, Solomon DH, Katz JN, St\u00fcrmer T (2010) Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf 19:2\u20139. https:\/\/doi.org\/10.1002\/pds.1845","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7677_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/aje\/kwi106","volume":"161","author":"T St\u00fcrmer","year":"2005","unstructured":"St\u00fcrmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ (2005) Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol 161:891\u2013898. https:\/\/doi.org\/10.1093\/aje\/kwi106","journal-title":"Am J Epidemiol"},{"key":"7677_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/ede.0000000000000627","volume":"28","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Hern\u00e1ndez-D\u00edaz S, Solomon DH, Jackson JW, Gagne JJ, Glynn RJ, Franklin JM (2017) Matching weights to simultaneously compare three treatment groups: comparison to three-way matching. Epidemiology 28:387\u2013395. https:\/\/doi.org\/10.1097\/ede.0000000000000627","journal-title":"Epidemiology"},{"key":"7677_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","volume":"60","author":"G Heinze","year":"2018","unstructured":"Heinze G, Wallisch C, Dunkler D (2018) Variable selection - a review and recommendations for the practicing statistician. Biom J 60:431\u2013449. https:\/\/doi.org\/10.1002\/bimj.201700067","journal-title":"Biom J"},{"key":"7677_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00198-003-1499-8","volume":"15","author":"D Pearson","year":"2004","unstructured":"Pearson D, Taylor R, Masud T (2004) The relationship between social deprivation, osteoporosis, and falls. Osteoporos Int 15:132\u2013138. https:\/\/doi.org\/10.1007\/s00198-003-1499-8","journal-title":"Osteoporos Int"},{"key":"7677_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.maturitas.2013.12.011","volume":"77","author":"MJ G\u00f3mez-de-Tejada Romero","year":"2014","unstructured":"G\u00f3mez-de-Tejada Romero MJ, Navarro Rodr\u00edguez MD, Saavedra Santana P, Quesada G\u00f3mez JM, J\u00f3dar Gimeno E, Sosa Henr\u00edquez M (2014) Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment. Maturitas 77:282\u2013286. https:\/\/doi.org\/10.1016\/j.maturitas.2013.12.011","journal-title":"Maturitas"},{"key":"7677_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-008-0697-9","volume":"20","author":"MC Navarro","year":"2009","unstructured":"Navarro MC, Sosa M, Saavedra P, Lainez P, Marrero M, Torres M, Medina CD (2009) Poverty is a risk factor for osteoporotic fractures. Osteoporos Int 20:393\u2013398. https:\/\/doi.org\/10.1007\/s00198-008-0697-9","journal-title":"Osteoporos Int"},{"key":"7677_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jamia\/ocv088","volume":"23","author":"AW Bazemore","year":"2016","unstructured":"Bazemore AW, Cottrell EK, Gold R, Hughes LS, Phillips RL, Angier H, Burdick TE, Carrozza MA, DeVoe JE (2016) \u201cCommunity vital signs\u201d: incorporating geocoded social determinants into electronic records to promote patient and population health. J Am Med Inform Assoc: JAMIA 23:407\u2013412. https:\/\/doi.org\/10.1093\/jamia\/ocv088","journal-title":"J Am Med Inform Assoc: JAMIA"},{"key":"7677_CR33","doi-asserted-by":"publisher","first-page":"e214299","DOI":"10.1001\/jamahealthforum.2021.4299","volume":"2","author":"S Park","year":"2021","unstructured":"Park S, Stimpson JP (2021) Trends in self-reported forgone medical care among Medicare beneficiaries during the COVID-19 pandemic. JAMA Health Forum 2:e214299. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.4299","journal-title":"JAMA Health Forum"},{"key":"7677_CR34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s10900-017-0367-y","volume":"42","author":"LB Scott","year":"2017","unstructured":"Scott LB, Crnosija N, Riaz M, Edelman NH (2017) Low income suburban residents perceive a greater lack of specialty but not primary care physicians than those with higher incomes. J Community Health 42:1173\u20131178. https:\/\/doi.org\/10.1007\/s10900-017-0367-y","journal-title":"J Community Health"},{"key":"7677_CR35","doi-asserted-by":"publisher","first-page":"e0180017","DOI":"10.1371\/journal.pone.0180017","volume":"12","author":"S Lee","year":"2017","unstructured":"Lee S, Seo DH, Kim KM, Lee EY, Kim HC, Kim CO, Youm Y, Rhee Y (2017) Contingent association between the size of the social support network and osteoporosis among Korean elderly women. PLoS ONE 12:e0180017. https:\/\/doi.org\/10.1371\/journal.pone.0180017","journal-title":"PLoS ONE"},{"key":"7677_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12160-014-9663-2","volume":"49","author":"ME Magrin","year":"2015","unstructured":"Magrin ME, D\u2019Addario M, Greco A, Miglioretti M, Sarini M, Scrignaro M, Steca P, Vecchio L, Crocetti E (2015) Social support and adherence to treatment in hypertensive patients: a meta-analysis. Ann Behav Med 49:307\u2013318. https:\/\/doi.org\/10.1007\/s12160-014-9663-2","journal-title":"Ann Behav Med"},{"key":"7677_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/aje\/kwr143","volume":"174","author":"PG Arbogast","year":"2011","unstructured":"Arbogast PG, Ray WA (2011) Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders. Am J Epidemiol 174:613\u2013620. https:\/\/doi.org\/10.1093\/aje\/kwr143","journal-title":"Am J Epidemiol"},{"key":"7677_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.amjmed.2006.03.029","volume":"120","author":"MA Brookhart","year":"2007","unstructured":"Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H, Solmon DH (2007) Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med 120:251\u2013256. https:\/\/doi.org\/10.1016\/j.amjmed.2006.03.029","journal-title":"Am J Med"},{"key":"7677_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1062860607307990","volume":"22","author":"PF Cook","year":"2007","unstructured":"Cook PF, Emiliozzi S, McCabe MM (2007) Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings. Am J Med Qual 22:445\u2013456. https:\/\/doi.org\/10.1177\/1062860607307990","journal-title":"Am J Med Qual"},{"key":"7677_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archinternmed.2011.1977","volume":"172","author":"DH Solomon","year":"2012","unstructured":"Solomon DH, Iversen MD, Avorn J et al (2012) Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 172:477\u2013483. https:\/\/doi.org\/10.1001\/archinternmed.2011.1977","journal-title":"Arch Intern Med"},{"key":"7677_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s40618-022-01820-8","volume":"45","author":"S De Vincentis","year":"2022","unstructured":"De Vincentis S, Domenici D, Ansaloni A, Boselli G, D\u2019Angelo G, Russo A, Taliani E, Rochira V, Simoni M, Madeo B (2022) COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine. J Endocrinol Invest 45:1887\u20131897. https:\/\/doi.org\/10.1007\/s40618-022-01820-8","journal-title":"J Endocrinol Invest"},{"key":"7677_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/pop.2021.0343","volume":"25","author":"BP Sen","year":"2022","unstructured":"Sen BP, Sharma P, Brisendine A, Blackburn J, Morrisey M, Menachemi N, Liu Y, McDougal J, Sanders T, Becker D (2022) Disparities in telehealth utilization in a population of publicly insured children during the COVID-19 pandemic. Popul Health Manag 25:178\u2013185. https:\/\/doi.org\/10.1089\/pop.2021.0343","journal-title":"Popul Health Manag"},{"key":"7677_CR43","doi-asserted-by":"publisher","first-page":"e43965","DOI":"10.2196\/43965","volume":"25","author":"R D'Amico","year":"2023","unstructured":"D\u2019Amico R, Schnell PM, Foraker R, Olayiwola JN, Jonas DE, Brill SB (2023) The evolution of primary care telehealth disparities during COVID-19: retrospective cohort study. J Med Internet Res 25:e43965. https:\/\/doi.org\/10.2196\/43965","journal-title":"J Med Internet Res"},{"key":"7677_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/1472-6963-14-469","volume":"14","author":"\u00c1 Lubl\u00f3y","year":"2014","unstructured":"Lubl\u00f3y \u00c1 (2014) Factors affecting the uptake of new medicines: a systematic literature review. BMC Health Serv Res 14:469. https:\/\/doi.org\/10.1186\/1472-6963-14-469","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"7677_CR45","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07677-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:31:06Z","timestamp":1764682266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07677-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7677"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07677-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded in part by UAB P30 (P30AR072853). YL, TA, JZ, KS, and JC have received research support from Amgen. JC has been a consultant to Amgen. HY currently employed by GSK. BS, DB, RS declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}